PART I Forward-Looking Statements Unless the context indicates otherwise, as used in this Annual Report, the terms Nika, we, us, our, our company and our business refer, to Nika Pharmaceuticals, Inc.., including its subsidiaries. Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statemen...
Q2 FY2026 — expected 2026-09-24
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001826466-26-000026 | EDGAR | 16K words |
| 2025-03-31 | 2024-12-31 | 0001826466-25-000030 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001826466-24-000041 | EDGAR | — |
| 2023-04-10 | 2022-12-31 | 0001826466-23-000014 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001826466-22-000017 | EDGAR | — |
| 2021-03-24 | 2020-12-31 | 0001826466-21-000075 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001826466-25-000096 | EDGAR | 10K words |
| 2025-08-14 | 2025-06-30 | 0001826466-25-000087 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001826466-25-000058 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001826466-24-000146 | EDGAR | — |
| 2024-09-18 | 2024-06-30 | 0001826466-24-000120 | EDGAR | — |
| 2024-05-28 | 2024-03-31 | 0001826466-24-000068 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0001826466-23-000038 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001826466-23-000031 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001826466-23-000022 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001826466-22-000142 | EDGAR | — |
| 2022-08-22 | 2022-06-30 | 0001826466-22-000111 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001826466-22-000057 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2024-10-16 | 0001826466-24-000131 | EDGAR | 0K words |
| 2024-10-01 | 0001826466-24-000128 | EDGAR | — |
| 2024-08-27 | 0001826466-24-000096 | EDGAR | — |
| 2024-05-10 | 0001826466-24-000056 | EDGAR | — |
| 2024-04-15 | 0001826466-24-000050 | EDGAR | — |
| 2024-03-05 | 0001826466-24-000020 | EDGAR | — |
| 2024-02-16 | 0001826466-24-000005 | EDGAR | — |
| 2023-09-18 | 0001826466-23-000033 | EDGAR | — |
| 2022-11-15 | 0001826466-22-000149 | EDGAR | — |
| 2022-11-01 | 0001826466-22-000112 | EDGAR | — |
37 total filings indexed. 9 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001145604 |
| Ticker | NIKA |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | CO |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report